6 / 1096
Symposium with Proffered Papers
Novel approaches in brain matters ................................................................................Abs. 115-119
Symposium
Brachytherapy pays ....................................................................................................Abs. 120-123
Proffered Papers
Prostate ....................................................................................................................Abs. 124-130
Poster Viewing
Session 3: Treatment planning . ....................................................................................Abs. 131-138
Proffered Papers
Lung .........................................................................................................................Abs. 139-144
Joint Symposium
ESTRO-JASTRO: Oligometastatic disease ........................................................................Abs. 145-148
Proffered Papers
Best of particles .........................................................................................................Abs. 149-154
Imaging and image analysis .........................................................................................Abs. 155-160
Novelties in image guidance .........................................................................................Abs. 161-166
Symposium
Novel approaches in particle biology ..............................................................................Abs. 167-170
Proffered Papers
Prostate 1 . ................................................................................................................Abs. 171-176
Breast .......................................................................................................................Abs. 177-182
Poster Viewing
Session 4: Brachytherapy miscellaneous ........................................................................Abs. 183-190
Award Lecture
Honorary Members’ Award Lectures ...............................................................................Abs. 191-193
SUNDAY 7 MAY 2017
Teaching Lecture
Role of radiotherapy in extranodal lymphomas ...................................................................... Abs. 194
Strategies to increase safety in radiation oncology: how to make accidents
less likely to occur ............................................................................................................ Abs. 195
Automated planning, knowledge-based planning and other novel developments
in treatment planning - how do they work and perform? ......................................................... Abs. 196
Building of NTCP models that contain non-dosimetric parameters . ........................................... Abs. 197
Particle therapy: how to start up and carry out daily clinical practice ......................................... Abs 198
Three-dimensional organoid culture system .......................................................................... Abs. 199
Commissioning of dose calculations in brachytherapy TPS ....................................................... Abs. 200
Symposium
New developments in Personalised Radiation Oncology (PRO) . ..........................................Abs. 201-204
Safety and clinical and cost effectiveness of multi-modality IGRT and ART . .........................Abs. 205-208
Robust optimisation in protons and photons . ..................................................................Abs. 209-211
Ultra fast online therapy adaptation (replanning, dose accumulation QA) ............................Abs. 212-214
Particle theraphy: how to start up and carry out daily clinical practice ................................Abs. 215-217
Symposium with Proffered Papers
Combining tumour and normal tissue models ..................................................................Abs. 218-222
Symposium
Paediatric brachytherapy . ............................................................................................Abs. 223-225
Proffered Papers
Dose measurement and dose calculations . .....................................................................Abs. 226-232
Poster Viewing
Session 5: Lung and breast ..........................................................................................Abs. 233-241
Proffered Papers
Understanding RBE and its relevance in vivo ...................................................................Abs. 242-246
Joint Symposium
ESTRO-CARO: Waiting times and QA .............................................................................Abs. 247-250